Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



Drinks industry in the dark about blocked caffeine claims

By Lynda Searby , 21-Mar-2012

Europe’s coffee makers and energy drink manufacturers are perplexed as to why the EFSA-approved caffeine claims have been dropped from the draft positive list of general function claims.

There were originally five claims on the list: ‘caffeine helps to improve concentration’, ‘caffeine helps to increase alertness’, ‘caffeine contributes to a reduction in the rated perceived exertion/effort during endurance exercise’, ‘caffeine contributes to an increase in endurance performance’, and ‘caffeine contributes to an increase in endurance performance capacity’.

The first indication that these claims were in question came at the end of January when Paola Testori Coggi, director general of DG SANCO, revealed that the Commission was “reflecting on caffeine”.

Claims on hold

Following subsequent discussions between the Commission and member states, the claims were put on an ‘on hold’ list pending further consideration.

As to why this decision was taken, Europe’s coffee producers seem to be in the dark.

“We are aware of the fact some caffeine health claims have been put ‘on hold’ for further consideration of the Commission and member states. We do not formally know the reason why,” Francesco Tramontin, director sustainability with Kraft Food Europe, told

Similarly, energy drink giant Red Bull said: “Given EFSA’s positive opinion on the caffeine claims, we were surprised to learn about the delay in their adoption.”

Not even the European Coffee Federation, which represents the industry’s interests at an EU level, appears to know exactly what is going on.

Consumption level concerns

Speaking in relation to the two caffeine-related claims supported by the Federation, namely ID 736 (alertness) and ID 737 (endurance performance), secretary general Roel Vaessen told  

“We have not been officially informed why ID 736 and ID 737 have not yet been included in the list of permitted claims, but informal feedback suggests that authorities in some member states are concerned that health claims related to caffeine may cause an increase in consumption, especially of high-caffeine containing soft drinks.”

He dismissed the suggestion that health claims might lead to increased caffeine consumption, saying: “Any possible concern over excessive intake is unfounded because the claimed effects occur at normal consumption levels. EFSA has established an effective dose of 75mg caffeine for the alertness and concentration claims and a dose of 3-4mg/kg of body weight for the athletic claims, which would result in an intake of 210-280mg for a 70kg person. There is no scientific data to support any concern with these levels.”

In fact, he pointed out that these levels are even below the maximum recommended caffeine intake of 300mg/day for pregnant women.

He said the Federation is working to transfer the two claims from the ‘on hold’ list to the list of permitted claims. 

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars